activism and education to defeat aging
"We are on the verge of a revolution in medicine: understanding, treating, and ultimately preventing the causes of degenerative aging. But medical revolutions only happen if we all stand up in support of funding and research. We did it for cancer. We're doing it for Alzheimer's. We can do it for aging - and create an era of longer, healthier lives!"
Home Search Take Action! Articles Daily News Newsletter Fight Aging! Blog Press Room Resources About Contact
Hot Topics: Activism - Anti-Aging - Calorie Restriction - Cryonics - Negligible Senescence - Our Community - Research Prizes - Stem Cells - Transhumanism
Start Here!
Are you new to healthy life extension? Click here to find out more about living a longer, healthier life. More >>
Take Action!
You can help to make therapies for aging and life extension medicine a reality. Click here to participate in improving your future health and longevity!
LM Newsletter
Sign up for our weekly newsletter! It contains news, opinions, and commentary for people interested in healthy life extension: making use of diet, lifestyle choices, technology, and proven medical advances to live longer, healthier lives.

Requested Daily News Article

Progress in Bypassing Mitochondrial Damage (Friday September 05 2008)
Allotopic expression of genes normally found in mitochondrial DNA is a core portion of the Strategies for Engineered Negligible Senescence. It is the process of inserting a copy of vital mitochondrial genes into the cell nucleus, and then figuring out how to get the proteins produced by those genes back to the mitochondria where they are needed. This could eliminate the contribution of mitochondrial DNA damage to aging. A technique for doing all this is now demonstrated in rats: "We obtained a complete and long-term restoration of mitochondrial function in human fibroblasts in which the mitochondrial genes ATP6, ND1, and ND4 were mutated ... ND1 and ND4 are mutated in nearly all cases of Leber hereditary optic neuropathy (LHON). LHON is the most common mitochondrial disorder and is characterized by a loss of vision. ... They introduced the human ND4 gene with the mutation present in the majority of LHON patients into rat eyes. The treatment caused retinal ganglion cells (RGCs) to degenerate significantly when compared to those from control eyes and was associated with decreased visual performance. Importantly, reintroducing normal ND4 led to prevention of RGC loss and visual impairment, effectively rescuing the animals from impending blindness. ... These data represent the 'proof of principle' that optimized allotropic expression is effective in vivo and can be envisaged as a therapeutic approach for mtDNA-related diseases."
Link to original article  
Share |
 

Prior News

Later News

We help you stay up to date with the most interesting news in medicine, politics and the healthy life extension community. You can help us by contacting us when you see interesting items online. You can search past news postings through Google by using the form to the right.
Search Past News

   

Search